FDA Envisions International Focus Groups Navigating Globalization Issues
This article was originally published in The Tan Sheet
Executive Summary
FDA could help create several international coalitions to carry out the agency’s globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
You may also be interested in...
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations
FDA better allocated resources for foreign inspections based on information European and Australian authorities shared in a two-year pilot program, including conducting good manufacturing practices inspections that met the needs of multiple agencies.
FDA Global Pharma Safety Plan Looks To Food Model
FDA seeks new authority over the international drug supply chain to support a global safety plan.